Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.50
Bid: 100.00
Ask: 105.00
Change: -2.50 (-2.38%)
Spread: 5.00 (5.00%)
Open: 105.00
High: 105.00
Low: 102.50
Prev. Close: 105.00
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer and General Meeting

1 Jul 2020 12:46

RNS Number : 7408R
Feedback PLC
01 July 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR").

Feedback plc

Result of Open Offer and General Meeting

London, 1 July 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announced on 15 June 2020, that it had conditionally raised £5.05 million through the placing of 505,000,000 new ordinary shares in the Company, and, in addition, had provided all qualifying shareholders with the opportunity to subscribe for an aggregate of up to 53,994,991 new ordinary shares at the issue price of 1 penny per share, pursuant to the Open Offer.

Result of Open Offer

Feedback announces that valid applications were received in respect of, in aggregate, 21,981,769 Open Offer Shares, raising gross proceeds of £219,817.69. Therefore, the total amount raised pursuant to the Placing and Open Offer is approximately £5.27 million. Both the Open Offer and the Placing were conditional on shareholder approval at the general meeting held earlier today.

Result of General Meeting

The Company announces that, at its general meeting held earlier today, all resolutions were duly passed. As a result, the 505,000,000 Placing Shares and 21,981,769 Open Offer Shares are expected to be admitted to trading on AIM on 3 July 2020 ("Admission"). The proxy voting results of the resolutions were as follows:

Resolutions

Votes For*

% of votes cast**

Votes Against

% of votes cast**

Votes Withheld**

Total votes cast**

Ordinary Resolutions

1. To authorise the directors to allot Ordinary Shares pursuant to the Placing and Open Offer

207,687,480

99.89

221,474

0.11

44,560

207,908,954

2. To authorise the directors to allot further shares (or grant rights in respect thereof) pursuant to Section 551 of the Companies Act 2006

207,657,443

99.89

221,474

0.11

74,597

207,878,917

Special Resolutions

3. General disapplication of pre-emption rights on Ordinary Shares pursuant to the Placing and Open Offer

207,657,443

99.89

221,474

0.11

74,597

207,878,917

4. To authorise the directors to allot further equity securities pursuant to Section 570 of the Companies Act 2006

207,657,443

99.89

221,474

0.11

74,597

207,878,917

 

*Votes "For" include votes giving the Chairman discretion.

** A 'Vote Withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution, nor in the "Total votes cast".

 

Director Shareholding

 

Rory Shaw, Chairman of Feedback, has subscribed for 416,667 new ordinary shares pursuant to the Open Offer. Therefore, from Admission, Rory Shaw will hold 4,583,334 ordinary shares, representing 0.43 per cent. of the Company's issued share capital. The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation, is appended below.

 

Total Voting Rights

On Admission, the Company will have 1,066,931,686 ordinary shares of 0.25p each in issue, each with one voting right. There are no shares held in treasury. Therefore, from Admission, the total number of ordinary shares and voting rights in the Company will be 1,066,931,686. 

The above figure of 1,066,931,686 may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Defined terms used in this announcement shall have the same meaning as in the announcement of 15 June 2020 unless otherwise defined herein.

Enquiries:

 Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

 

 

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

 

 

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

 

 

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

 

 

+44 20 3815 8880

Instinctif Partners

Melanie Toyne-Sewell / Phillip Marriage

+44 (0)20 7457 2020

+44 7890 022 814

feedbackplc@instinctif.com

 

Notes to editors

About Feedback plc - www.fbk.com

 

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

 

Feedback has launched Bleepa, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa  , see www.bleepa.com .

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rory Shaw

2

Reason for the notification

a)

Position/status

Chairman

b) 

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 0.25p each

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550 

b)

Nature of the transaction

Subscription of Ordinary Shares pursuant to the Open Offer

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

 1p

416,667

 

d)

Aggregated information 

- Aggregated volume

- Price

 

N/A

e)

Date of the transaction

1 July 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKDBQDBKDBOK
Date   Source Headline
25th Mar 20247:00 amRNSNew tuberculosis partnership in India
21st Mar 20247:00 amRNSFurther CDC Pilot Programme Secured
23rd Feb 202411:03 amRNSHolding(s) in Company
21st Feb 20247:00 amRNSHalf-year Report
21st Feb 20247:00 amRNSMedical Imaging Partnership Pilot Agreement
6th Feb 20247:00 amRNSNotice of Results & Investor Presentation
19th Dec 20237:01 amRNSHalf Year Trading Update
19th Dec 20237:00 amRNSAward of Pilot Funding
26th Oct 20232:24 pmRNSResult of AGM
25th Oct 20235:53 pmRNSDirector Dealing
27th Sep 202312:15 pmRNSNotice of AGM
12th Sep 20237:00 amRNSFinal Results
5th Sep 20237:00 amRNSNotice of Results & Investor Presentation
19th Jun 20237:00 amRNSYear End Trading Update
4th Apr 20237:00 amRNSBleepa-CareLocker contract extension with QVH
7th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:56 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSNotice of Results, Analyst & Investor Presentation
22nd Dec 202212:08 pmRNSDirector/PDMR Shareholding: Correction
22nd Dec 20227:00 amRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSHalf Year Trading Update
1st Nov 20223:36 pmRNSTotal Voting Rights
13th Oct 20222:55 pmRNSResult of AGM & Proposed Share Consolidation
29th Sep 20223:46 pmRNSHolding(s) in Company
20th Sep 20223:26 pmRNSNotice of AGM & Proposed Share Consolidation
20th Sep 20227:00 amRNSFinal Results
13th Sep 20227:00 amRNSNotice of Results & Investor Presentation
6th Sep 20227:00 amRNS12 month contract for Sussex CDC pilot extension
19th Jul 20227:00 amRNSContract Update
16th Jun 20227:00 amRNSYear End Trading Update
1st Jun 20227:00 amRNSTrading Update & Director Appointment
12th May 202212:44 pmRNSChange of Registered Office
12th Apr 20227:00 amRNSBleepa wins two NHS Contract Awards
31st Mar 20227:00 amRNSBleepa TB Screening Pilot Now Live in Odisha
23rd Feb 20227:00 amRNSGrant of Options and PDMR dealing
10th Feb 20227:00 amRNSInterim Results
31st Jan 20227:00 amRNSNotice of Results
13th Dec 20217:00 amRNSPartnership with Amazon Web Services
6th Dec 20213:06 pmRNSHolding(s) in Company
2nd Dec 202110:20 amRNSDirector/PDMR Shareholding
2nd Dec 20219:54 amRNSHolding(s) in Company
1st Dec 20214:27 pmRNSHolding(s) in Company
1st Dec 20213:09 pmRNSHolding(s) in Company
30th Nov 20214:05 pmRNSHolding(s) in Company
29th Nov 20211:36 pmRNSDirector Appointment
29th Nov 20211:35 pmRNSResults of AGM, Open Offer, Issue of Equity & TVR
18th Nov 202112:15 pmRNSHolding(s) in Company
16th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20211:52 pmRNSResult of Placing
2nd Nov 20217:01 amRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.